CD44 and cancer: The system also enriched cancer stem-like properties, with higher expression of stemness-associated genes (CD24, CD44, CD133, ALDHA1, CXCR4, Sox2, Oct4, Nanog, and KLF4) and expansion of CSC populations expressing (CD44, CD90, CD117, EpCAM, and CK19).